GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Microbio Co 4128.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

13.55

+1.88%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Microbio Co

Its shares trade on Taipei Exchange under the ticker 4128.TWO. It has been listed since 10 February 2003. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.89bn and a net loss of TWD 757.7m. At that date it held total assets of TWD 12.33bn and shareholders' equity of TWD 8.91bn.

Microbio Co., Ltd. engages in the research, development, manufacture, and sale of new drugs and healthcare products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2003-02-10. The firm provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The firm mainly distributes its products mainly within domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
10 Feb 2003

Leadership

Pay as last reported

  • Mr. Hsien-Shou KuoChairman of the Board, since 2021TWD 3.0m
  • Ms. Ying-Chun WangAssistant General Manager of Finance, Chief Corporate Governance OfficerTWD 1.9m
  • Mr. Zhenwen ChenGeneral Manager, Director, since 2024
  • Ms. Wan-Jiun ChenDeputy General Manager-Research & Development Center, since 2022TWD 2.4m
  • Mr. Tsu-Der LeeDirector
  • Jinghong LuDirector
  • Mr. Chun-Chao ChangIndependent Director
  • Mr. Li-Chun HanIndependent DirectorTWD 386,000
  • Mr. Chi-Ming LiangIndependent DirectorTWD 621,000
  • Ms. Wen-Mien WuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company engages in research and development of new drugs.
  • It manufactures fermentation products like Tien Chun Bao oral solutions.
  • It offers herbal products including the LeeHerb series.

Weaknesses

  • The firm mainly distributes products within the domestic market.
  • It operates in the consumer staples sector.
  • It is headquartered in Taipei City.

Opportunities

  • It sells organic foods such as vegetables and fruits.
  • It provides medicines for hepatitis and allergies.
  • It offers anticancer medicines to patients.

Threats

  • The source description is treated as untrusted facts.
  • Market expansion is limited to the domestic region.
  • Competition exists in the consumer products industry.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.